Press monitoring
US Trade representative Rob Portman and U.S. Agriculture Secretary Mike Johanns on agricultural biotechnology and the WTO
2.3.2006 | Press monitoring
"Today, news reports have stated the World Trade Organization (WTO) has preliminarily found the European Union has a de facto moratorium on agricultural biotechnology products that is inconsistent with WTO rules."
South Africa: GM debate fought over cotton fields
2.3.2006 | Press monitoring
Taking a break from spraying his neat, one-hectare plot of young cotton plants with herbicide, Moses Mabika surveys the land that has been supporting his family for 45 years. He may not realise it, but he is standing at the epicenter of a heated debate about growing genetically modified (GM) crops in Africa.
Global BioExecutive Program
2.3.2006 | Press monitoring
This is the last week to register for the Global BioExecutive Program at the UC Berkeley Haas School of Business Center for Executive Development. Register now to reserve your space and join world renowned faculty from Columbia, Harvard, and UC Berkeley, industry experts such from Merck, Genentech, Chiron, and other top bioscience firms (click...
Buckyballs may bind to DNA
1.3.2006 | Press monitoring
Researchers from Oak Ridge National Laboratory and Vanderbilt University in the US have found that C60 molecules (buckyballs) are likely to bind strongly to single and double-stranded DNA in an aqueous environment.
Romanian GM ban criticized by biotech industry
1.3.2006 | Press monitoring
Europes biotech industry has criticised Romania's proposed ban on transgenic soybeans, claiming that the decision will negatively impact both the European food industry and consumers.
GM debate: Question time
1.3.2006 | Press monitoring
Austria takes consumer concerns about GM food very seriously argues Josef Proell as he outlines how Vienna will tackle this “very emotive subject.”
Europe rejects genetically engineered drug
1.3.2006 | Press monitoring
European regulators declined yesterday to approve what would have been the first drug produced in the milk of genetically engineered animals, dealing a setback to a fledgling industry that aims to convert cows, goats and rabbits into low-cost pharmaceutical factories.
Genzyme Ends Enrollment in Phase 2 Trial of Cardiac Cell Therapy
1.3.2006 | Press monitoring
Corporation announced today that it has ceased to enroll new patients in its Phase 2 cardiac cell therapy trial.
Embryonic Stem Cell Research Moves Another Step Ahead
1.3.2006 | Press monitoring
Melbourne scientists have identified a new method of detecting abnormal embryonic stem cells before they change into cancerous cells -- a discovery which could circumvent one of the greatest challenges facing this field of research.
Protein molecule isolated as neurodegenerative drug target
1.3.2006 | Press monitoring
Researchers have isolated a protein molecule that may hold the key to learning and memory disorders that have been linked with autism. By isolating this potential drug target, new therapies for diseases in which synapses either fail or proliferate out of control could be produced.
